In vitro studies and animal models have shown that anti-MBG antibodies and ADA-FAB can reverse the NKA inhibitory effect of EDLF in preeclampsia, and anti-MBG antibodies are also effective in reversing vascular fibrosis. This evidence concerns the gene ADA and preeclampsia.